Betibeglogene autotemcel (beti-cel) gene therapy for the treatment of Transfusion-Dependent β-Thalassemia (TDT): Updated long-term efficacy and safety results

被引：0
|
作者：
Kulozik, A. E. [1 ]
Thuret, I [2 ]
Thompson, A. A. [3 ]
Kwiatkowski, J. L. [4 ]
Porter, J. B. [5 ]
Hongeng, S. [6 ]
Yannaki, E. [7 ]
Sauer, M. G. [8 ]
Thrasher, A. J. [9 ]
Lal, A.
Du, L. [10 ]
Colvin, R. A. [11 ]
Walters, M. C. [12 ]
Locatelli, F. [13 ]
机构：
[1] Heidelberg Univ, Univ Med Ctr Children & Adolescents, Heidelberg, Germany
[2] Marseille Univ, Dept Pediat Hematol, Marseille, France
[3] Feinberg Sch Med, Hematol Sect, Chicago, IL USA
[4] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA USA
[5] UCL, Dept Haematol, London, England
[6] Ramathibodi Hosp, Dept Pediat, Fac Med, Bangkok, Thailand
[7] G Papanicolaou Hosp, Hematol Dept Hematopoiet Cell Transplantat Unit, Gene & Cell Therapy Ctr, Thessaloniki, Greece
[8] Hannover Med Sch, Pediat Hematol & Oncol, Hannover, Germany
[9] Great Ormond St Hosp Sick Children, London, England
[10] UCSF Benioff Childrens Hosp, Oakland, CA USA
[11] Bluebird Bio Inc, Cambridge, England
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
[13] Osped Pediat Bambino Gesu, Dept Pediat Hematol Oncol, Rome, Italy
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V293
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [31] Long-term efficacy and safety of elivaldogene autotemcel (eli-cel) gene therapy: an integrated analysis of 67 patients with cerebral adrenoleukodystrophy (CALD)
    Eichler, F.
    Duncan, C.
    Kuhl, J-S
    De Oliveira, S.
    Thrasher, A.
    Dalle, J-H
    Sevin, C.
    Shah, A.
    Locatelli, F.
    Amartino, H.
    Engelen, M.
    Downey, G.
    Dietz, A.
    Orchard, P.
    Williams, D.
    Thakar, Himal
    ANNALS OF NEUROLOGY, 2023, 94 : S135 - S135
  • [32] Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Non-β0/β0 Genotypes
    Thompson, Alexis A.
    Walters, Mark C.
    Kwiatkowski, Janet L.
    Hongeng, Suradej
    Porter, John B.
    Sauer, Martin G.
    Thrasher, Adrian J.
    Thuret, Isabelle
    Elliot, Heidi
    Tao, Ge
    Colvin, Richard A.
    Locatelli, Franco
    BLOOD, 2019, 134
  • [33] Favorable Outcomes in Pediatric Patients in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia
    Thompson, Alexis A.
    Kwiatkowski, Janet L.
    Porter, John B.
    Hongeng, Suradej
    Yannaki, Evangelia
    Kulozik, Andreas E.
    Sauer, Martin G.
    Thrasher, Adrian J.
    Thuret, Isabelle
    Lal, Ashutosh
    Guo, Ruiting
    Liu, Weijian
    Colvin, Richard A.
    Walters, Mark C.
    Locatelli, Franco
    BLOOD, 2020, 136
  • [34] The long-term efficacy in blood transfusions, hematologic parameter changes, and complications after splenectomy in patients with transfusion-dependent thalassemia
    Osataphan, Nichanan
    Dumnil, Somying
    Tantiworawit, Adisak
    Punnachet, Teerachat
    Hantrakun, Nonthakorn
    Piriyakhuntorn, Pokpong
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Chai-Adisaksopha, Chatree
    Rattarittamrong, Ekarat
    Norasetthada, Lalita
    Fanhchaksai, Kanda
    Charoenkwan, Pimlak
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (03)
  • [35] Lentiglobin Gene Therapy for Patients with Transfusion-Dependent β-Thalassemia (TDT): Results from the Phase 3 Northstar-2 and Northstar-3 Studies
    Locatelli, Franco
    Walters, Mark C.
    Kwiatkowski, Janet L.
    Porter, John
    Sauer, Martin G.
    Thuret, Isabelle
    Hongeng, Suradej
    Kulozik, Andreas E.
    Lal, Ashutosh
    Thrasher, Adrian J.
    Yannaki, Evangelia
    Elliot, Heidi
    Tao, Ge
    Asmal, Mohammed
    Thompson, Alexis A.
    BLOOD, 2018, 132
  • [36] Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia
    Wanless, IR
    Sweeney, G
    Dhillon, AP
    Guido, M
    Piga, A
    Galanello, R
    Gamberini, MR
    Schwartz, E
    Cohen, AR
    BLOOD, 2002, 100 (05) : 1566 - 1569
  • [37] Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-Dependent β-thalassemia (TDT): A Long-Term Retrospective Analysis
    De Sanctis, Vincenzo
    Soliman, Ashraf T.
    Tzoulis, Ploutarchos
    Daar, Shahina
    Di Maio, Salvatore
    Fiscina, Bernadette
    Kattamis, Christos
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13
  • [38] Effect of Luspatercept on Red Blood Cell (RBC) Transfusion Burden, Iron Chelation Therapy (ICT), and Iron Overload in Adults with Transfusion-Dependent ß-Thalassemia (TDT) from the BELIEVE Trial: A Long-Term Analysis
    Hermine, Olivier
    Cappellini, Maria Domenica Domenica
    Taher, Ali T.
    Coates, Thomas D.
    Viprakasit, Vip
    Kattamis, Antonis
    Shetty, Jeevan K.
    Weisskopf, Marija Bosilkovska
    Holot, Natalia
    Vodala, Sadanand
    Kuo, Wen-Ling
    Porter, John B.
    BLOOD, 2022, 140 : 8215 - 8217
  • [39] Results from the Hgb-207 (Northstar-2) Trial: A Phase 3 Study to Evaluate Safety and Efficacy of Lentiglobin Gene Therapy for Transfusion-Dependent ß-Thalassemia (TDT) in Patients with Non-ß0/ß0 Genotypes
    Walters, Mark C.
    Hongeng, Suradej
    Kwiatkowski, Janet L.
    Locatelli, Franco
    Porter, John B.
    Sauer, Martin G.
    Thrasher, Adrian J.
    Thuret, Isabelle
    Yannaki, Evangelia
    Elliot, Heidi
    Gayron, Marisa
    Asmal, Mohammed
    Thompson, Alexis A.
    BLOOD, 2017, 130
  • [40] Long-Term Follow-up of β-Transfusion-Dependent Thalassemia (TDT) Normoglycemic Patients with Reduced Insulin Secretion to Oral Glucose Tolerance Test (OGTT): A Pilot Study
    de Sanctis, Vincenzo
    Soliman, Ashraf T.
    Daar, Shahina
    Tzoulis, Ploutarchos
    Di Maio, Salvatore
    Kattamis, Christos
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13
12345